B. C. Ross

发表

Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor.

A. Mcelroy, R. Hagan, S. Ireland, 1992, Journal of medicinal chemistry.

Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.

J. Wright, S. Jevons, K. Richardson, 1977, The Journal of antibiotics.

A convenient strategy for replacement of the anomeric hydroxyl group by difluoromethyl functionality in carbohydrate derivatives

David J. Williams, A. Slawin, M. Tozer, 1993 .

Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo.

B. Fitzgerald, A. Baxter, R. Williams, 1992, The Journal of biological chemistry.

The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.

C. Chan, B. Dymock, J. Scicinski, 1996, Journal of medicinal chemistry.

Pharmacological profile of GR117289 in vitro: a novel, potent and specific non‐peptide angiotensin AT1 receptor antagonist

J. Barnes, F. Marshall, K. Clark, 1992, British journal of pharmacology.

A CONVENIENT METHOD FOR REPLACEMENT OF THE ANOMERIC HYDROXY GROUP IN CARBOHYDRATES BY DIFLUOROMETHYL FUNCTIONALITY

M. Tozer, W. Motherwell, B. C. Ross, 1989 .

Conformationally constrained tachykinin analogues: potent and highly selective neurokinin NK-2 receptor agonists.

A. Mcelroy, R. Hagan, S. Ireland, 1992, Journal of medicinal chemistry.

Bromobenzofurans : a new class of potent, non-peptide antagonists of angiotensin II

J. Montana, K. Clark, M. J. Robertson, 1991 .

Novel peptide surrogates: The retroreduced isostere

B. Ross, M. M. Campbell, G. Semple, 1989 .

Inhibitors of cholesterol biosynthesis. 2. 3,5-Dihydroxy-7-(N-pyrrolyl)-6-heptenoates, a novel series of HMG-CoA reductase inhibitors.

P. Procopiou, G. Inglis, N. S. Watson, 1993, Journal of medicinal chemistry.

Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.

M. J. Robertson, D. Judd, G. M. Drew, 1995, The Journal of pharmacology and experimental therapeutics.

Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability.

D. Scopes, D. Judd, M. Dowle, 1994, Journal of medicinal chemistry.

Synthesis of the staurosporine aglycon

C. Moody, Kulsum F. Rahimtoola, B. Porter, 1992 .

5,5-trans lactone-containing inhibitors of serine proteases: identification of a novel, acylating thrombin inhibitor.

J. Montana, C. Dix, H. Finch, 1998, Bioorganic & medicinal chemistry letters.

Synthesis of trans-fused [5,5] bicyclic lactones/lactams as templates for serine protease inhibition

J. Montana, H. Finch, H. A. Kelly, 1998 .

Spirocyclic side-chain derivatives of penicillin and cephalosporin

Steven J. Smith, B. C. Ross, P. Sammes, 1985 .

Benzofuran based angiotensin II antagonists related to GR117289: enhancement of potency in vitro and oral activity

J. Montana, K. Clark, M. J. Robertson, 1993 .